These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 7337972

  • 1. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD, Ewel C, Londono S, Metzger Z, Hoffeld JT, Oppenheim JJ.
    Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
    [Abstract] [Full Text] [Related]

  • 2. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI, Bostick-Bruton F.
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
    Haim N, Meidav A, Samuelly B, Segal R, Mekori T, Robinson E.
    J Biol Response Mod; 1984 Oct; 3(2):219-25. PubMed ID: 6233397
    [Abstract] [Full Text] [Related]

  • 4. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J, Levanon M, Davidsohn J, Ramot B.
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [Abstract] [Full Text] [Related]

  • 5. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM, Herzig GP.
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [Abstract] [Full Text] [Related]

  • 6. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
    Sibbitt WL, Bankhurst AD, Williams RC.
    J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
    [Abstract] [Full Text] [Related]

  • 7. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW, Reeves WG, Paolozzi FP, Poiesz BJ, Comis RL, Tomar RH.
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
    Sagone AL, Husney R, Guter H, Clark L.
    J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295
    [Abstract] [Full Text] [Related]

  • 10. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM, Huang AT, Kremer WB.
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [Abstract] [Full Text] [Related]

  • 11. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
    Bockman RS.
    J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
    [Abstract] [Full Text] [Related]

  • 12. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G, Chastenay BF, Krawitt EL.
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B, Rosenthal E, Biniaminov M, Ben-Bassat I.
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P, Velardi A, Spinozzi F, Falini B, Martelli MF.
    Boll Ist Sieroter Milan; 1979 Mar 31; 58(1):90-9. PubMed ID: 552840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC.
    N Engl J Med; 1977 Nov 03; 297(18):963-8. PubMed ID: 409950
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.